EZSolution™ Saracatinib
-
Catalog numberB2625-5
-
PricePlease ask
-
Size5 mg
-
-
Alternative_nameAZD0530, N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine, AZD-0530
-
DescriptionA 10 mM (5 mg in 922 µl) solution of the dual inhibitor of the tyrosine kinases c-Src and Abl Saracatinib (AZD-0530) (Cat. No. 1582) in anhydrous DMSO.
-
CAS Number379231-04-6
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₇H₃₂ClN₅O₅
-
Molecular Weight542.03
-
Cell PermeableTrue
-
Purity≥98% by HPLC
-
HandlingDo not take internally. Wear gloves and mask when handling the product! Avoid contact by all modes of exposure.
-
Tag LineA c-Src and Bcr-Abl inhibitor
-
Storage Condition-20ºC
-
Shipping ConditionGel Pack
-
Shelf Life36 months
-
PubChem CID10302451
-
SMILESCN1CCN(CC1)CCOC2=CC3=C(C(=C2)OC4CCOCC4)C(=NC=N3)NC5=C(C=CC6=C5OCO6)Cl
-
InChiInChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)
-
InChi KeyOUKYUETWWIPKQR-UHFFFAOYSA-N
-
MSDS AvailableFalse
-
Gene target
-
Short nameEZSolution™ Saracatinib
-
Alternative nameEZSolution™ Saracatinib
-